Call My Doctor Expands 24/7 Doctor On Call Services with DHA-Certified Medical Care Across Dubai
Get fast, professional medical care with DHA-certified doctors on call across Dubai. Home, hotel, or office visits available 24/7. Book now!
'Our mission is to deliver professional, compassionate medical care to every doorstep in Dubai—whenever and wherever it's needed.'— Founder, Call My Doctor (CMD)
DUBAI, DUBAI, UNITED ARAB EMIRATES, June 16, 2025 / EINPresswire.com / -- Call My Doctor, a leading Dubai-based healthcare provider, has announced the expansion of its Doctor On Call Dubai services, offering 24/7 medical care in Dubai with a team of DHA-certified doctors. This around-the-clock service delivers urgent medical care directly to patients – whether at home, in a hotel, or at the workplace – providing a fast, convenient alternative to clinic visits.
Dubai's fast-paced lifestyle and round-the-clock business environment have created a growing demand for convenient, high-quality healthcare services. Call My Doctor's 24/7 doctor-on-call service is designed to meet this need by bringing urgent medical care Dubai residents can rely on straight to their doorsteps. Patients benefit from same-day appointments, personalized one-on-one consultations, and care from DHA-certified doctors in Dubai, all without the hassle of traveling to a clinic or hospital.
'Our mission is to take the stress out of medical treatment by delivering high-quality care in the comfort of the patient's home – in fact, we are bringing the hospital to them, not the other way around,' said a Call My Doctor spokesperson. 'This initiative marks a significant milestone in our goal to make healthcare easily accessible and convenient for everyone.'
Comprehensive Treatments Available Anytime, Anywhere
With Call My Doctor's on-call service, patients can receive a broad range of medical treatments at any time of day. The visiting doctors are equipped to handle acute illnesses, minor injuries, and routine health needs for all ages. Services include:
- General health check-ups and preventive care
- Diagnosis and treatment of common ailments – e.g. flu, fever, infections
- Management of chronic conditions – such as diabetes or hypertension
- Pediatric care at home for children's illnesses and checkups
- Minor wound care and injury treatment (cuts, sprains, burns)
- Vaccinations and IV therapy at home, plus on-site lab tests and diagnostics
DHA-Certified Doctors You Can Trust
All physicians and nurses with Call My Doctor are fully DHA-certified, licensed by the Dubai Health Authority, and have extensive clinical experience in their fields. Each house-call is carried out with strict adherence to international standards of safety, hygiene, and professionalism, so patients can trust that they are in expert hands.
Call My Doctor promises a rapid response time – often dispatching a qualified physician within 30–45 minutes of a request – so patients get timely care without long ER waits or exposure to hospital crowds.
This commitment to excellence has earned Call My Doctor a strong reputation in the community. The service boasts an average rating of 4.5 out of 5 stars based on hundreds of patient reviews. Clients frequently praise the company's reliability and compassionate care.
Call to Action:
Dubai residents and visitors in need of prompt medical attention can access Call My Doctor's Doctor On Call service 24/7 by calling +971 4 549 0700 (or toll-free 800 99387). A DHA-licensed doctor will be dispatched to the location of your choice within minutes. For more information or to schedule a visit, visit the official website at https://callmydoctor.ae or email [email protected].
About Call My Doctor
Call My Doctor is a Dubai-based home healthcare provider specializing in on-demand doctor house calls and comprehensive medical services delivered at patients' doorsteps. Founded with the vision of making healthcare more accessible, convenient, and personalized, the company has quickly established itself as a trusted leader in 24/7 home healthcare across the UAE.
Media Contact:
Call My Doctor – Healthcare Services
Address: AB Center, Sheikh Zayed Road, Al Barsha 1, Dubai, UAE
Phone: +971 4 549 0700 | Toll Free: 800 99387
Email: [email protected]
Website: https://callmydoctor.ae/
Jay
Call My Doctor
email us here
Visit us on social media:
Instagram
Facebook
TikTok
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
an hour ago
- Wall Street Journal
Defending RFK Jr.'s Adviser
In your editorial 'Meet RFK Jr.'s Vaccine Advisers' (June 13), you write of the secretary's new plans for the Advisory Committee on Immunization Practices: 'One appointee, Retsef Levi, is an MIT business school professor of operations management. What does he know about vaccines?' Allow me to rise to my colleague's defense. The members of ACIP don't develop vaccines. They are charged with assessing their safety and efficacy. That is done through statistics and data science, areas in which Mr. Levi excels. His assessments will be conducted through vaccine trials, using a statistically significant number of participants and correlating the efficacy with a host of variables such as age, comorbidity, gender and dosage. The primary tool available to the researchers is statistical modeling. Only after discovering correlations may medical researchers try to explain them, but that is a secondary part of the trials.
Forbes
an hour ago
- Forbes
The Data Tsunami In Today's Interoperable And AI World
David Lareau is CEO of Medicomp Systems, which makes medical data relevant, usable and actionable. getty Artificial intelligence (AI) systems have seemingly taken healthcare—and perhaps the world—by storm, showing great promise for revolutionizing care, research, workflows and more. As the industry evaluates what's AI hype versus true potential, one thing about AI has become clear: It generates a massive amount of data—which for healthcare creates both opportunities and challenges. Now that interoperability pipes are live and data is flowing between healthcare organizations, providers are managing a tsunami of incoming data. With AI and large language models (LLMs), it has become easier to generate even more data, which means the problem has just worsened. And unlike a regular tsunami, healthcare's giant wave of incoming data is not a one-time event. The data will continue to accumulate. What are healthcare organizations to do to keep from drowning in all the data? Despite early hopes that AI might solve data challenges, the bloom is now off that rose and users are realizing that AI needs to be a bit more reliable, accurate and trustworthy for critical healthcare tasks. Accurate clinical records are vital for patient care, reimbursement and operational efficiencies. When a physician creates a clinical note, they are responsible for ensuring the documentation is accurate and complete. With interoperability, we now have a wealth of additional clinical information coming from other clinicians, hospitals, labs, HIEs and other sources. While, on the surface, more information seems powerful, clinicians now need to figure out if the incoming data is accurate and what pieces are relevant for the patient in front of them. In other words, if clinicians are responsible for the incoming tsunami of data, how can they efficiently verify and manage it all? Consider the impact of AI-assisted documentation tools, which aim to optimize workflows, reduce documentation times and relieve physician burnout. Their output, however, is only as good as the data being fed into the systems. If a healthcare organization is building AI initiatives using data from a repository filled with errors or gaps, the resulting output will be flawed. Transparency is thus essential when it comes to AI data. When documentation is created through AI, healthcare providers need to understand the source of truth behind an assessment or recommendation so they can quickly identify potential errors that might impact patient care. Another limitation of conversational AI is the inability to create structured data. While these tools may be excellent at creating narrative text, they often fail to create the structured clinical data needed for analytics, regulatory compliance and quality metrics. AI-assisted documentation tools also rely heavily on summarization, which can be beneficial when trying to quickly make sense of a compilation of dozens of multiple-page medical records. LLMs, however, are trained to identify the next logical word, with very little reasoning behind them. To drive accuracy, these models should be trained on expertly curated clinical content using advanced algorithms. AI is also imperfect for coding, especially when derived from erroneous or incomplete documentation. Incorrect diagnosis and procedure codes can create downstream problems, including denied claims, inaccurate reimbursement and inappropriate follow-up patient care. Healthcare enterprises using AI to generate content that becomes part of a patient's medical record should consider the following: 1. Who is responsible for the final review and approval of AI-generated content that becomes part of a medical record? 2. Where in the workflow does this happen, and how are changes or corrections made and communicated to all members of the care team? 3. Organizations should consult with clinical users to obtain agreement on how information is presented, enabling those who sign off on care plans to view documentation and, if necessary, act upon the information presented to them. 4. The organization should implement a feedback loop so users can let system and workflow designers know of issues with AI-generated content and suggest refinements and improvements. To effectively manage today's tsunami of clinical data, especially in this era of interoperability and AI, clinicians need tools that can transform huge volumes of clinical data into a source of truth. This requires technologies that leverage trusted, curated clinical content to validate AI-generated outputs. To be useful for clinicians at the point of care, these tools should also sort and filter data and create structured, discrete information that is mapped to standard terminologies, value sets and reporting formats. Healthcare's data tsunami is not going away. However, by embracing tools that pair with AI outputs to improve data quality, clinicians can be empowered with rapid access to accurate and actionable data that enhances patient care. Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
Washington Post
2 hours ago
- Washington Post
FDA to offer faster drug reviews to companies promoting 'national priorities'
WASHINGTON — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting 'the health interests of Americans,' under a new initiative announced Tuesday. Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA's long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases . Regular drug reviews take about 10 months. Since arriving at the FDA in April, Makary has repeatedly told FDA staff they need to 'challenge assumptions' and rethink procedures. In a medical journal commentary published last week, Makary suggested the agency could conduct 'rapid or instant reviews,' pointing to the truncated process used to authorize the first COVID-19 vaccines under Operation Warp Speed. For the new program, the FDA will issue a limited number of 'national priority vouchers' to companies 'aligned with U.S. national priorities,' the agency said in a statement. The special designation will give the selected companies access to extra FDA communications, streamlined staff reviews and the ability to submit much of their product information in advance. Speeding up drug approvals has long been a priority of the pharmaceutical industry, which has successfully lobbied Congress to create a variety of special programs and pathways for faster reviews. Many aspects of the plan announced Tuesday overlap with older programs. But the broad criteria for receiving a voucher will give FDA officials unprecedented discretion in deciding which companies can benefit from the fastest reviews. 'The ultimate goal is to bring more cures and meaningful treatments to the American public,' Makary said in a statement. Makary previously said the FDA should be willing to ease its scientific requirements for certain drugs, for instance, by not always requiring randomized studies in which patients are tracked over time to track safety and effectiveness. Such trials are generally considered the gold standard of medical research, though the FDA has increasingly been willing to accept smaller, less-definitive studies for rare or life-threatening diseases . In several recent cases , the FDA has faced criticism for approving drugs based on preliminary data that didn't ultimately show benefits for patients. The push to rapidly accelerated drug approvals is the opposite approach that Makary and his boss, Health Secretary Robert F. Kennedy Jr. , have taken on vaccines. Promising a 'return to gold-standard science,' Kennedy previously announced that all new vaccines would have to be compared to placebo, or a dummy shot, to win approval. Kennedy and Makary also have announced a stricter policy on seasonal updates to COVID-19 shots, saying they will have to undergo new testing before they can be approved for use in healthy children and most adults. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
